Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,435 | 1,456 | 1,266 | 1,451 | 383 |
| Operating Income | -1,435 | -1,456 | -1,266 | -1,451 | -383 |
| Interest Expense | 0 | 0 | 0 | -5 | 12 |
| Other Income | 37 | 34 | 4 | 466 | -652 |
| Pre-tax Income | -1,398 | -1,422 | -1,262 | -980 | -1,047 |
| Net Income Continuous | -1,398 | -1,422 | -1,262 | -980 | -1,047 |
| Net Income | $-1,398 | $-1,422 | $-1,262 | $-980 | $-1,047 |
| EPS Basic Total Ops | -0.07 | -0.08 | -0.08 | -0.08 | -0.10 |
| EPS Basic Continuous Ops | -0.07 | -0.08 | -0.08 | -0.08 | -0.10 |
| EPS Diluted Total Ops | -0.07 | -0.08 | -0.08 | -0.08 | -0.10 |
| EPS Diluted Continuous Ops | -0.07 | -0.08 | -0.08 | -0.08 | -0.10 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.08 | -0.08 | -0.08 | -0.10 |
| EBITDA(a) | $-735 | $-118 | $-1,226 | $-1,411 | $-228 |